Amedisys to Acquire Asana Hospice
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: GlobeNewswire
BATON ROUGE, La., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire Asana Hospice. Under the terms of the agreement, targeted to close on January 1, 2020, Amedisys will acquire 100 percent of the ownership interests in Asana Hospice. Asana provides hospice care to approximately 540 patients daily in eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas. “I’m honored to welcome Asana Hospice’s dedicated and compassionate team to the Amedisys family of caregivers,” stated Amedisys CEO and President Paul Kusserow. “Our two organizations share a commitment to putting excellent patient care at the forefront of everything we do, and I know our strengthened family will continue to deliver clinical distinction to these communities for years to come.” On the close of the agreement, Amedisys will operate 146 hospice care centers in 33 stat
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.MarketBeat
- UnitedHealth deal for Amedisys likely to close despite report of DOJ scrutiny - analyst [Seeking Alpha]Seeking Alpha
- Why Amedisys (AMED) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 3/19/24 - Form 8-K
- 2/22/24 - Form 10-K
- 2/21/24 - Form 4
- AMED's page on the SEC website